These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9247154)

  • 1. Studies on ion channel antagonist-binding sites in sunflower protoplasts.
    Vallée N; Brière C; Petitprez M; Barthou H; Souvré A; Alibert G
    FEBS Lett; 1997 Jul; 411(1):115-8. PubMed ID: 9247154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of putative calcium channels (phenylalkylamine-binding sites) on oil bodies in protoplasts from dark-grown sunflower seedling cotyledons.
    Vandana S; Bhatla SC
    Plant Signal Behav; 2009 Jul; 4(7):604-9. PubMed ID: 19820351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observation of polarity induction by cytochemical localization of phenylalkylamine-binding sites in regenerating protoplasts of the moss Physcomitrella patens.
    Bhatla SC; Kiessling J; Reski R
    Protoplasma; 2002 Feb; 219(1-2):99-105. PubMed ID: 11926072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel antagonists induce direct inhibition of the outward rectifying potassium channel in tobacco protoplasts.
    Thomine S; Zimmerman S; Van Duijn B; Barbier-Brygoo H; Guern J
    FEBS Lett; 1994 Feb; 340(1-2):45-50. PubMed ID: 8119406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular studies of the calcium antagonist binding site on calcium channels.
    Schwartz A
    Am J Cardiol; 1994 Mar; 73(6):12B-14B. PubMed ID: 8141073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
    Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
    Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterogeneity of the slow channel blockers (calcium antagonists).
    Nayler WG
    Int J Cardiol; 1983 Jul; 3(4):391-400. PubMed ID: 6350195
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural model for phenylalkylamine binding to L-type calcium channels.
    Cheng RCK; Tikhonov DB; Zhorov BS
    J Biol Chem; 2009 Oct; 284(41):28332-28342. PubMed ID: 19700404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
    Minarovic I; Mészáros LG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular action of calcium channel blocking drugs.
    Schwartz A; Triggle DJ
    Annu Rev Med; 1984; 35():325-39. PubMed ID: 6372660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-dependent cooperative interactions of calcium channel ligands in intact cardiac cells.
    Porzig H; Kokubun S; Prod'hom B; Becker C; Reuter H
    Biomed Biochim Acta; 1987; 46(8-9):S370-4. PubMed ID: 2449182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type calcium channel antagonism - Translation from in vitro to in vivo.
    Fermini B; Ramirez DS; Sun S; Bassyouni A; Hemkens M; Wisialowski T; Jenkinson S
    J Pharmacol Toxicol Methods; 2017; 84():86-92. PubMed ID: 27856310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.